Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss National Survey
about
Current treatment of atypical mycobacteriosisMycobacterium kansasii Subtype I Is Associated With Clarithromycin Resistance in ChinaMethodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other MycobacteriaActivation of an NLRP3 inflammasome restricts Mycobacterium kansasii infectionCombined rpoB duplex PCR and hsp65 PCR restriction fragment length polymorphism with capillary electrophoresis as an effective algorithm for identification of mycobacterial species from clinical isolatesBiodiversity of amoebae and amoeba-resisting bacteria in a hospital water networkIdentification of Mycobacterium species by secA1 sequencesDraft Genome Sequences of Mycobacterium kansasii Clinical StrainsEvaluation of the GenoType Mycobacterium Assay for identification of mycobacterial species from cultures.Molecular analysis of Mycobacterium kansasii isolates from the United States.Evaluation of a modified single-enzyme amplified-fragment length polymorphism technique for fingerprinting and differentiating of Mycobacterium kansasii type I isolates.Assessment of partial sequencing of the 65-kilodalton heat shock protein gene (hsp65) for routine identification of Mycobacterium species isolated from clinical sourcesChronotype Modulates Language Processing-Related Cerebral Activity during Functional MRI (fMRI).Clinical Significance of Mycobacterium kansasii Isolates from Respiratory Specimens.Comprehensive multicenter evaluation of a new line probe assay kit for identification of Mycobacterium species and detection of drug-resistant Mycobacterium tuberculosis.Draft Genome Sequences of Mycobacterium kansasii Strains 1010001454, 1010001458, 1010001468, 1010001493, 1010001495, and 1010001469, Isolated from Environmental Sources.Insights on the emergence of Mycobacterium tuberculosis from the analysis of Mycobacterium kansasii.Applying the One Health Concept to Mycobacterial Research - Overcoming Parochialism.Mycobacterium kansasii-induced death of murine macrophages involves endoplasmic reticulum stress responses mediated by reactive oxygen species generation or calpain activation.Non-tuberculous mycobacteria: epidemiological pattern in a reference laboratory and risk factors associated with pulmonary disease.Evaluation of the Ribosomal Protein S1 Gene (rpsA) as a Novel Biomarker for Mycobacterium Species Identification.Comparative in vitro activities of linezolid, telithromycin, clarithromycin, levofloxacin, moxifloxacin, and four conventional antimycobacterial drugs against Mycobacterium kansasii.Effect of phenolic glycolipids from Mycobacterium kansasii on proinflammatory cytokine release. A structure-activity relationship study.Rapid susceptibility testing for slowly growing nontuberculous mycobacteria using a colorimetric microbial viability assay based on the reduction of water-soluble tetrazolium WST-1.Current methods in the molecular typing of Mycobacterium tuberculosis and other mycobacteria.Non-tuberculous Mycobacteria isolated from lymph nodes and faecal samples of healthy slaughtered cattle and the abattoir environment.Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium kansasii.Molecular typing of Mycobacterium kansasii using pulsed-field gel electrophoresis and a newly designed variable-number tandem repeat analysis.MALDI Spectra Database for Rapid Discrimination and Subtyping of Mycobacterium kansasii.Short communication: subtyping of Mycobacterium kansasii by PCR-restriction enzyme analysis of the hsp65 gene.Whole genome sequence of Mycobacterium kansasii isolates of the genotype 1 from Brazilian patients with pulmonary disease demonstrates considerable heterogeneity.Therapy for Infection: Beyond 2018
P2860
Q28265322-2B5AF217-1F74-424E-B0E6-1786A077DAE6Q28354212-23C43379-7A9C-42AC-8D06-F6F0FA40E082Q28389409-0937078A-8A98-4843-BEFC-5635908CCF57Q28730209-B58FCDBA-0F6E-4E0B-A3D7-1ECA6FF55498Q31071504-F10E3BBE-3184-4B06-A89F-28E067E1528AQ33239056-57EED111-3E9D-434F-997C-D09B14AE1329Q33753061-FD2EF4E7-4486-4FC7-96F7-541B442AEAC6Q33753594-F74B387C-6DE2-4824-BCFA-B1E59B73837AQ34680903-2B642C58-85D5-41E0-B404-1F1562DA1008Q35551413-33C25A58-654E-473B-B097-5DCCF8842A8FQ35637353-A797C56D-16FB-4D1F-981D-17173ADBA2B0Q35718284-4D5B2EE5-1087-4476-9DB9-BD76B226B82EQ35784784-07B2DD68-5DAF-4EB1-BDF5-07B54B3E1923Q35797447-00719933-6C4E-4172-9BA5-24A420FD34BDQ35807187-0E97110F-AB17-4C7E-912D-40E879D93C3EQ36964747-24E2927B-84E3-45FB-B425-1786678FBE8AQ37661334-A353B8D2-1210-4978-B199-101A4C35C1F5Q39085452-04163AFF-5455-4432-8171-B5C754D68B5BQ39221452-CDDA5CBA-414F-40B3-8845-DC6B504CC44EQ39224852-17D9496D-2FED-45CC-9DE4-45E16A37C979Q39763537-9C68F6F1-9016-4B10-8968-7B77398F7CB2Q40425898-7EFEC55C-AE2D-4938-AA2A-58C56220C5C8Q41005889-80AD8822-E7FF-46C6-994C-8EFC43A20B6DQ41108850-03B83216-C1EE-4795-9604-C702D1153E8CQ41771085-94C80E76-0BA9-4800-8209-A2CE7F05FFCBQ46237699-B2777DBE-3DC0-419A-A9D1-0A1F49FBD7B3Q50044334-098C548D-25D5-410D-9218-EE49CA3D4DEFQ52657288-AD49FA00-993F-454F-8524-B71A58BE884AQ52718413-7A4E96CF-4AB2-4247-918B-34AAE5B619F4Q54332823-CDEC2846-73DE-4AC0-B99F-5F122BB5883AQ55437497-98700E5C-38BC-48EE-BE22-1C82DE0AC01DQ57492415-23CEA591-6192-4027-90D3-532CD1439480
P2860
Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss National Survey
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Clinical implications of Mycob ...... geneity: Swiss National Survey
@ast
Clinical implications of Mycob ...... geneity: Swiss National Survey
@en
Clinical implications of Mycob ...... geneity: Swiss National Survey
@nl
type
label
Clinical implications of Mycob ...... geneity: Swiss National Survey
@ast
Clinical implications of Mycob ...... geneity: Swiss National Survey
@en
Clinical implications of Mycob ...... geneity: Swiss National Survey
@nl
prefLabel
Clinical implications of Mycob ...... geneity: Swiss National Survey
@ast
Clinical implications of Mycob ...... geneity: Swiss National Survey
@en
Clinical implications of Mycob ...... geneity: Swiss National Survey
@nl
P2093
P2860
P1476
Clinical implications of Mycob ...... geneity: Swiss National Survey
@en
P2093
Amalio Telenti
Caroline Taillard
Gaby E Pfyffer
Guy Prod'hom
Jacques Bille
Jean-Claude Piffaretti
Peter Rohner
Rainer Weber
Stefan Zimmerli
P2860
P304
P356
10.1128/JCM.41.3.1240-1244.2003
P407
P577
2003-03-01T00:00:00Z